Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bispecific T-cell engaging antibodies against MUC16 demonstrate efficacy against ovarian cancer in monotherapy and in combination with PD-1 and VEGF inhibition
    Journal Article

    Yeku, O. O.; Rao, T. D.; Laster, I.; Kononenko, A.; Purdon, T. J.; Wang, P.; Cui, Z.; Liu, H.; Brentjens, R. J.; Spriggs, D.
    Frontiers in Immunology (2021)

    Fulltext@MSK | Save
  • “Interferon” with MPN hematopoietic stem cells
    Editorial

    Dunbar, A.; Levine, R. L.
    Blood (2021)

    Fulltext@MSK | Save
  • The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis
    Journal Article

    Fidler, T. P.; Xue, C.; Yalcinkaya, M.; Hardaway, B.; Abramowicz, S.; Xiao, T.; Liu, W.; Thomas, D. G.; Hajebrahimi, M. A.; Pircher, J.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • Incorporation of novel therapies for the treatment of acute myeloid leukemia: A perspective
    Review

    Waksal, J. A.; Tallman, M. S.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
    Research Letter

    Chowdhury, O.; O’Sullivan, J.; Barkas, N.; Wang, G.; Buck, G.; Hamblin, A.; Tefferi, A.; Al-Ali, H. K.; Barosi, G.; Devos, T.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer
    Journal Article

    Dao, T.; Klatt, M. G.; Korontsvit, T.; Mun, S. S.; Guzman, S.; Mattar, M.; Zivanovic, O.; Kyi, C. K.; Socci, N. D.; O’Cearbhaill, R. E.; more...
    Cancer Immunology, Immunotherapy (2021)

    Fulltext@MSK | Save
  • BL-8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open-label safety and efficacy phase 2a study
    Journal Article

    Borthakur, G.; Ofran, Y.; Tallman, M. S.; Foran, J.; Uy, G. L.; DiPersio, J. F.; Showel, M. M.; Shimoni, A.; Nagler, A.; Rowe, J. M.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy
    Research Letter

    Ball, B. J.; Hsu, M.; Devlin, S. M.; Arcila, M.; Roshal, M.; Zhang, Y.; Famulare, C. A.; Goldberg, A. D.; Cai, S. F.; Dunbar, A.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • DOT1L inhibitors block abnormal self-renewal induced by cohesin loss
    Journal Article

    Heimbruch, K. E.; Fisher, J. B.; Stelloh, C. T.; Phillips, E.; Reimer, M. H. Jr; Wargolet, A. J.; Meyer, A. E.; Pulakanti, K.; Viny, A. D.; Loppnow, J. J.; more...
    Scientific Reports (2021)

    Fulltext@MSK | Save
  • Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
    Journal Article

    Glass, J. L.; Derkach, A.; Hilden, P.; King, A.; Seo, S. K.; Ahr, K.; Kishtagari, A.; Levine, R. L.; Tallman, M. S.; Douer, D.
    Leukemia Research (2021)

    Fulltext@MSK | Save